FERRARI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 28.863
NA - Nord America 26.104
AS - Asia 11.155
SA - Sud America 1.849
Continente sconosciuto - Info sul continente non disponibili 295
AF - Africa 292
OC - Oceania 52
Totale 68.610
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.572
IT - Italia 18.346
GB - Regno Unito 3.955
CN - Cina 3.165
SG - Singapore 2.980
NL - Olanda 1.393
BR - Brasile 1.377
VN - Vietnam 1.321
HK - Hong Kong 1.248
SE - Svezia 880
DE - Germania 866
FR - Francia 696
UA - Ucraina 656
FI - Finlandia 541
BD - Bangladesh 503
RU - Federazione Russa 437
KR - Corea 406
TR - Turchia 393
IN - India 260
CA - Canada 252
BG - Bulgaria 231
CH - Svizzera 222
MX - Messico 158
ID - Indonesia 147
AR - Argentina 133
ES - Italia 94
JP - Giappone 91
IE - Irlanda 85
IQ - Iraq 80
EC - Ecuador 79
PL - Polonia 69
ZA - Sudafrica 68
PK - Pakistan 66
CO - Colombia 64
CL - Cile 61
IR - Iran 55
AU - Australia 48
BE - Belgio 46
MY - Malesia 46
EG - Egitto 45
PH - Filippine 44
CZ - Repubblica Ceca 43
AE - Emirati Arabi Uniti 42
MA - Marocco 42
PE - Perù 42
SA - Arabia Saudita 40
TW - Taiwan 37
VE - Venezuela 36
GR - Grecia 35
UZ - Uzbekistan 33
TN - Tunisia 31
PY - Paraguay 29
CR - Costa Rica 28
AT - Austria 25
DK - Danimarca 25
DZ - Algeria 25
KE - Kenya 25
EU - Europa 24
RO - Romania 24
SK - Slovacchia (Repubblica Slovacca) 24
TH - Thailandia 24
HU - Ungheria 23
PT - Portogallo 22
JM - Giamaica 21
RS - Serbia 21
NP - Nepal 20
LT - Lituania 19
BO - Bolivia 18
DO - Repubblica Dominicana 18
AZ - Azerbaigian 16
JO - Giordania 16
IL - Israele 14
NO - Norvegia 12
AL - Albania 11
KZ - Kazakistan 11
NG - Nigeria 11
SN - Senegal 11
OM - Oman 10
PR - Porto Rico 10
BY - Bielorussia 9
ET - Etiopia 9
HN - Honduras 9
KG - Kirghizistan 9
LB - Libano 9
PA - Panama 9
SI - Slovenia 9
UY - Uruguay 9
GE - Georgia 8
HR - Croazia 8
MN - Mongolia 8
BH - Bahrain 7
LU - Lussemburgo 7
LV - Lettonia 7
QA - Qatar 7
TT - Trinidad e Tobago 7
AM - Armenia 6
EE - Estonia 6
PS - Palestinian Territory 6
YE - Yemen 6
GT - Guatemala 5
Totale 68.257
Salva come PNG Salva come JPEG
Città #
Southend 2.835
Ashburn 2.258
Santa Clara 2.037
Milan 1.994
Fairfield 1.875
Singapore 1.849
Woodbridge 1.381
Jacksonville 1.289
Hong Kong 1.223
Chandler 1.146
Houston 973
Hefei 870
Rome 804
Wilmington 736
Ann Arbor 727
Chicago 714
Dearborn 709
Seattle 706
Beijing 666
Cambridge 645
San Jose 619
Jersey City 591
Los Angeles 523
Turin 504
London 503
Nyköping 476
Ho Chi Minh City 438
Seoul 338
Council Bluffs 334
Helsinki 329
The Dalles 309
Hanoi 306
Salt Lake City 286
Florence 265
Princeton 255
Modena 249
Genoa 241
New York 234
Bologna 220
Brescia 220
Sofia 220
Eugene 206
Izmir 199
Lauterbourg 181
San Diego 177
Dallas 175
Moscow 150
Redwood City 144
Naples 142
Buffalo 141
Elk Grove Village 140
Tampa 129
São Paulo 123
Verona 113
Orem 110
Bergamo 104
Shanghai 95
Frankfurt am Main 89
Monza 86
Sterling 85
Jakarta 81
Trenton 81
Falls Church 77
Perugia 77
Dublin 76
Des Moines 74
Da Nang 72
Palermo 72
Padova 71
Parma 71
Columbus 69
Lancaster 66
Catania 65
Boardman 64
Pescara 64
Bari 61
Chennai 60
Miami 60
Tokyo 60
Norwalk 56
Haiphong 55
Toronto 55
Guangzhou 53
Brooklyn 52
Venice 52
Trieste 51
Munich 50
Phoenix 47
Mexico City 46
Nanjing 46
Fremont 45
Atlanta 44
Dulles 44
Paris 42
Reggio Emilia 42
Bremen 41
Detroit 41
Montreal 41
Rio de Janeiro 40
Trento 38
Totale 37.788
Salva come PNG Salva come JPEG
Nome #
Monitoraggio dei pazienti con uso/abuso alcolico mediante la determinazione dell'Etil glucuronide (EtG) nel capello 11.026
Krokodil: The drug that kills 6.122
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.254
Atogepant: an emerging treatment for migraine 968
Allopregnanolone serum levels in female migraineurs 879
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors 737
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 674
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 515
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients 499
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 496
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 480
Methadone - metabolism, pharmacokinetics and interactions 462
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study 461
Effective prophylactic treatments of migraine lower plasma glutamate levels 460
Tramadol chronic abuse: An evidence from hair analysis by LC tandem MS 439
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ) 437
Past, present, and future prospects of medication-overuse headache classification 431
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 431
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 427
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients 424
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 418
Clinical pharmacology of topiramate in migraine prevention 414
How children and parents evaluate the headache centre's intervention 409
Monitoring of adherence to headache treatments by means of hair analysis 402
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 401
Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments 399
Effect of sumatriptan in different models of pain in rats 394
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 390
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 384
Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone 384
Similarities and differences between chronic migraine and episodic migraine 382
Paracetamol: new vistas of an old drug 380
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments 373
Basal cutaneous pain threshold in headache patients 372
Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy 365
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 363
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 362
Adverse reactions related to drugs for headache treatment: clinical impact 359
Le neuropatie da farmaci 358
Headache: one of the most common and troublesome adverse reactions to drugs. 349
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 346
Abuse of tramadol in a binge pattern in a young woman 345
Paracetamol revisited 344
Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage 330
Analgesic drug taking: Beliefs and behavior among headache patients 329
Farmacologia e Tossicologia 307
Zopiclone and prazepam dependance: role of hair analysis for the monitoring of treatment in a migraine patient 304
Sucrose intake: Increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73 302
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal from the overused combination of indomethacin, Prochlorperazine and caffeine 300
Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report 299
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 293
Focus on headache as an adverse reaction to drugs 288
Italian guidelines for primary headaches: 2012 revised version. 288
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 286
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 286
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. 271
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 270
Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis 268
Pharmacoepidemiology of triptans in a headache centre 268
Polypharmacy Among Headache Patients: A Cross-Sectional Study 267
Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente 265
Different effect of sumatriptan in models of thermal, chemical or cephalalgic pain, in rats 264
Dehydroepiandrosterone Sulfate, Dehydroepiandrosterone, 5α-Dihydroprogesterone and Pregnenolone: Serum Analysis and Correlation Between Migraine and Non-headache Control Females 259
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 258
Hair testing as a marker of adherence to headache treatments 255
Glutamate receptor antagonists with the potential for migraine treatment 253
Proteomic serum profile in menstrual-related and post menopause migraine 252
Analgesic abuse in chronic headache sufferers 251
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 251
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 249
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 247
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 243
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 242
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 240
Assessment of the efficacy and tolerability of triptans in clinical practice 237
Evalutation of proteomic profile in menstrually-related migraine 236
Proteomic serum profile of female migraineurs 235
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 234
Adolescenza, sostanze stupefacenti, riti di passaggio 234
Activity of cromolyn sodium in dietary migraine: a double-blind placebo controlled multicenter trial 232
Clinical considerations preliminary to application of the Italian Society for the Study of Headache’s guidelines regarding migraine prophylactic treatment 230
Tramadol Abuse in a Binge Pattern in a Young Depressed Woman 230
Azioni, interazioni, controindicazioni, tossicità dei farmaci utilizzati nella terapia dell'emicrania 227
Accanimento terapeutico o riduzione del danno 227
Hypertension and migraine comorbidity: Prevalence and risk of cerebrovascular events: Evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study) 227
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 225
Plasma glutathione level in chronic headache drug abuser patients 224
Headache as an Adverse Reaction to Medication 223
Trattamento farmacologico del dolore postoperatorio 223
Folate, vitamin B12, and serum homocysteine levels in patients with chronic migraine and medication-overuse headache 222
Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration 218
Trattamento farmacologico integrato per la terapia delle tossicodipendenze 218
Dehydroepiandrosterone sulfate, dehydroepiandrosterone, 5α-dihydroprogesterone and pregnenolone in women with migraine: analysis of serum levels and correlation with age, migraine years and frequency 216
Zopiclone and prazepam abuse in a chronic migraine patient 215
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 213
Evaluation of proteomic profile in menstrual-related migraine 209
Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study 208
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 208
Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis 207
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients 207
Totale 51.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 202.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.493 169 519 430 465 191 223 256 296 449 315 568 612
2022/20235.226 494 438 281 409 526 604 248 531 682 252 426 335
2023/20246.492 276 362 371 578 746 468 719 722 389 501 685 675
2024/202512.633 679 491 494 937 1.951 1.498 1.029 909 1.428 869 1.196 1.152
2025/202621.365 1.890 1.183 1.817 2.773 3.635 1.370 2.194 1.255 1.611 1.573 1.182 882
2026/20271.025 1.025 0 0 0 0 0 0 0 0 0 0 0
Totale 68.610